Drug intelligence / Profile preview

ALLO-ASC-TI

Development stage: Unknown
Lead developer: Anterogen
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intralesional, Subcutaneous, Intradermal, Intraarticular, Intravenous, Topical

Overview

ALLO-ASC-TI is an allogeneic adipose-derived mesenchymal stem cell (ASC) therapy developed by the South Korean biotechnology company Anterogen. The product consists of expanded mesenchymal stem cells derived from the adipose tissue of healthy donors. It is primarily being developed for the treatment of tendon injuries, including lateral epicondylitis (tennis elbow) and rotator cuff tears. The therapeutic mechanism involves the secretion of various cytokines and growth factors that exert anti-inflammatory effects and promote the regeneration of damaged tendon tissue. ALLO-ASC-TI is administered via local injection directly into the site of the injury, where the cells modulate the local immune environment and stimulate endogenous repair processes.

Other names: allogeneic adipose-derived stem cellsallogeneic adipose-derived mesenchymal stem cellsallo-asc

Beyond the preview

Go deeper on ALLO-ASC-TI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALLO-ASC-TI.

Explore the full profile